Question 1

What is the catalog number for PT-179?

Accepted Answer

The catalog number for PT-179 is M37511.

Question 2

What sizes are available for PT-179?

Accepted Answer

PT-179 is available in the following size(s): 1 g, 200 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 500 mg.

Question 3

How many pack sizes does PT-179 come in?

Accepted Answer

PT-179 is available in 8 different pack sizes.

Question 4

Is PT-179 in stock?

Accepted Answer

PT-179 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is PT-179 used for?

Accepted Answer

PT-179 is a novel IMiD derivative, a molecular gel.

Question 6

What should I check when this product first arrives?

Accepted Answer

Inspect the package immediately for transportation damage, ice loss, leakage, or breakage. Report any issues right away with photos and your order reference; our specialists will determine whether the product is still usable or needs replacing.

Question 7

Does this cell line or biologic require a Material Transfer Agreement (MTA)?

Accepted Answer

Some products, including certain cell lines, plasmids, and tissue cultures, are subject to intellectual property terms and may require an MTA before we can ship. We’ll inform you in advance if this product requires one, and additional handling fees may apply.

Question 8

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

PT-179

Product Specifications

CAS Number

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

MCART2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

REST Antibody

REST Antibody

PRAME, CT (Preferentially Expressed Antigen of Melanoma, Melanoma Antigen Preferentially Expressed in Tumors, MAPE, CT130, OPA Interacting Protein 4, OPA-interacting Protein 4, Opa-interacting Protein OIP4, OIP4) (HRP)

PRAME, CT (Preferentially Expressed Antigen of Melanoma, Melanoma Antigen Preferentially Expressed in Tumors, MAPE, CT130, OPA Interacting Protein 4, OPA-interacting Protein 4, Opa-interacting Protein OIP4, OIP4) (HRP)

C4BPB 3'UTR Luciferase Stable Cell Line